Global Pulmonary Arterial Hypertension (PAH) Medicine Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report 2017-2022

SKU ID :HNY-10529219 | Published Date: 30-Jun-2017 | No. of pages: 190
This report focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applicationsand etc. Data type include capacity, production, market share, price, revenue, cost, gross, gross margin, growth rate, consumption, import, export and etc. Industry chain, manufacturing process, cost structure, marketing channel are also analyzed in this report.

This report provides valuable information for companies like manufacturers, suppliers, distributors, traders, customers, investors and individuals who have interests in this industry.

Major companies are as follows:
Actelion Pharmaceuticals
Gilead Sciences
United Therapeutics Corporation
GlaxoSmithKline
Pfizer
Bayer HealthCare
Arena Pharmaceuticals




Major classifications are as follows:
Endothelin Receptor Antagonists (ERA)
Prostacyclin And Prostacyclin Analogs
Phosphodiesterase 5 (PDE-5)

Major applications are as follows:
Secondary Pulmonary Hypertension (SPH)
Primary Pulmonary Hypertension (PPH)


Major regions are as follows:
Europe
North America
China
Japan
Southeast Asia
  • PRICE
  • $3500
    $10500
    Buy Now

Our Clients